Skip to main content

Opthea Ltd

CYVNY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001815620

No open-market purchases or sales by Opthea Ltd insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesCKDXF

13F holders, Q4 2024

Institutional positions in Opthea Ltd as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
11
+4 vs. Q3 2024
Shares held
5.40M
+171.0K (+3.3%) vs. Q3 2024
Total value
$21.2M
−$80.2K (−0.4%) vs. Q3 2024
New holders
6
1 more added
Sold out
2
1 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CYVNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 11 institutions
Q1 2021: 8 institutionsQ2 2021: 9 institutionsQ3 2021: 8 institutionsQ4 2021: 9 institutionsQ1 2022: 8 institutionsQ2 2022: 8 institutionsQ3 2022: 9 institutionsQ4 2022: 9 institutionsQ1 2023: 12 institutionsQ2 2023: 9 institutionsQ3 2023: 9 institutionsQ4 2023: 11 institutionsQ1 2024: 8 institutionsQ2 2024: 9 institutionsQ3 2024: 7 institutionsQ4 2024: 11 institutionsQ1 2025: 9 institutionsQ2 2025: 8 institutionsQ3 2025: 6 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2024: $21.2M
Q1 2021: $54.2MQ2 2021: $45.6MQ3 2021: $46.0MQ4 2021: $42.5MQ1 2022: $33.7MQ2 2022: $50.7MQ3 2022: $50.1MQ4 2022: $41.3MQ1 2023: $29.9MQ2 2023: $20.7MQ3 2023: $12.7MQ4 2023: $21.1MQ1 2024: $27.5MQ2 2024: $12.2MQ3 2024: $21.3MQ4 2024: $21.2MQ1 2025: $613.4KQ2 2025: $393.2KQ3 2025: $64.2KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CYVNY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20256$64.2K
Q2 20258$393.2K
Q1 20259$613.4K
Q4 202411$21.2M
Q3 20247$21.3M
Q2 20249$12.2M
Q1 20248$27.5M
Q4 202311$21.1M
Q3 20239$12.7M
Q2 20239$20.7M
Q1 202312$29.9M
Q4 20229$41.3M
Q3 20229$50.1M
Q2 20228$50.7M
Q1 20228$33.7M
Q4 20219$42.5M
Q3 20218$46.0M
Q2 20219$45.6M
Q1 20218$54.2M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Opthea Ltd; share changes are against Q3 2024.

Institutions holding CYVNY in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
VGI Partners Ltd2,907,403$11.4M1.16%00.0%Unchanged
Baker Bros. Advisors LP2,173,622$8.54M0.09%00.0%Unchanged
HSBC Holdings PLC142,515$555.8K0.00%+142,515New
Millennium Management LLC61,101$241.3K0.00%−6,291−9.3%Reduced
UBS Group AG36,757$144.4K0.00%+34,369+1,439.2%Added
Citadel Advisors LLC19,998$79.0K0.00%+19,998New
Twin Lakes Capital Management, LLC19,806$77.8K0.05%00.0%Unchanged
Susquehanna International Group, LLP12,311$48.6K0.00%+12,311New
Old Mission Capital LLC10,728$42.1K0.00%+10,728New
Abc Arbitrage SA10,216$40.1K0.01%+10,216New
Morgan Stanley3,365$13.2K0.00%+3,365New
Stratos Wealth Partners, LTD.0$00.00%−29,600−100.0%Sold out
Jane Street Group, LLC0$00.00%−26,632−100.0%Sold out